title: Re: Bicakli et al. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. J Oncol Pharm Pract, published online September 2014. DOI: 10.1177/1078155214551315.
authors.affiliation: Department of Biochemistry, Agri Military Hospital, Agri, Turkey mehmetagilli@yahoo.com.
authors.forename: Mehmet
authors.initials: M
authors.lastname: Agilli
authors.affiliation: Department of Biochemistry, Sirnak Military Hospital, Sirnak, Turkey.
authors.forename: Fevzi Nuri
authors.initials: FN
authors.lastname: Aydin
mesh_terms: D001943:Breast Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects*; D005260:Female; D006801:Humans; D024821:Metabolic Syndrome / Q000139:chemically induced* / Q000175:diagnosis*; D012307:Risk Factors